1. Introduction {#sec1}
===============

Salmonellosis is a common disease. The strains of*Salmonella enterica* are not responsible for typhoid fever but mainly for enteric infections; however, the commonest serovar, Typhimurium, may cause systemic infections, especially in immunocompromised patients and children with malnutrition, severe anemia, and malaria \[[@B1], [@B2]\]. Strains of*Salmonella* resistant to multiple antibiotics are being isolated more and more frequently. Thus, the commonly used antibiotics have become inefficient \[[@B3]\] and have had to be replaced by more expensive drugs \[[@B4]\]. The latest surveys conducted in the Central African Republic (CAR) showed a high prevalence of resistance to ampicillin and cotrimoxazole \[[@B5]\], which is increasing with time. To confirm this evolution, we determined the antibiotic resistance of strains of*S. enterica* isolated in 2008. Furthermore, we examined multiresistant strains of*S.* Typhimurium by genic amplification for the presence of nine of the commonest genes associated with antibiotic resistance.

2. Methods {#sec2}
==========

The study was performed in the unit of Clinical Bacteriology and Antibioresistance of the Institut Pasteur de Bangui between July and December 2008. Ninety-four strains of*Salmonella* were isolated, mainly from stools (56%) and blood (36%); two strains were from urine and one was from cerebrospinal fluid.*Salmonella* were identified on the basis of biochemical characteristics (API 20^*E*^ strips, bioMérieux, Craponne, France), and the serovar was determined according to the Kauffmann-White scheme. The Antimicrobial drug susceptibility was determined by using the disk diffusion method (Bio-Rad, Marnes-la-Coquette, France) on Mueller-Hinton Agar (MHA) and interpreted according to the recommendations of the Comité de l\'Antibiogramme de la Société Française de Microbiologie (CA-SFM) (<http://www.sfm-microbiologie.org/>). All isolates were tested for their susceptibility to antimicrobial agents routinely used in clinical practice for*Salmonella* infections in CAR. The antibiotics included ampicillin (25 *μ*g), amoxicillin (20 *μ*g), clavulanic acid (10 *μ*g), ticarcillin (75 *μ*g), cefalotin (30 *μ*g), cefotaxime (30 *μ*g), streptomycin (10 UI), gentamicin (15 *μ*g), nalidixic acid (30 *μ*g), ciprofloxacin (5 *μ*g), chloramphenicol (30 *μ*g), sulfonamides (200 *μ*g), and tetracycline (30 UI). If expanded-spectrum *β*-lactamase (ESBL) was found, additional antibiotics were tested (*β*-lactams and aminoglycosides). Strains were stored at −80°C in brain heart broth (Bio-Rad) with 20% glycerol.

Nine resistance-associated genes were sought by PCR with published techniques ([Table 1](#tab1){ref-type="table"}) on six randomly selected strains and the ESBL-producing strain. After subculture on Mueller-Hinton Agar (Bio-Rad), DNA was extracted from the bacterial suspensions by thermolysis at 100°C in a water bath for 5 min, followed by rapid cooling at 20°C. After centrifugation (8855 ×g, 10 min), the supernatant was used for DNA amplification. PCR were run on a Gene Amp PCR System 9700 Thermocycler (Applied Biosystems, Saint-Aubin, France) as described previously \[[@B6], [@B7], [@B8]\]. Amplicon sizes were determined, from a molecular mass ladder (SmartLadder SF, EuroGentec, Angers, France) by gel electrophoresis in 2% ethidium bromide (Eurobio, Les Ulis, France) containing agarose (Invitrogen, Cergy-Pontoise, France) in Tris-acetate buffer at pH 8 and run at 100 V, 200 mA for 1 h. Results were read under UV. One negative (sterile distilled water) and three positive (*S.* Concord*07-670*,*S.* Typhimurium*02-8213*, and*Shigella dysenteriae* 1 CAR 10) controls were included.

3. Results {#sec3}
==========

The 94 strains of*Salmonella* consisted of 47*S.e.* Typhimurium (50%), 21*S.e.* Stanleyville (22%), 18*S.e.* Enteritidis (19%), 4*S.e.* Dublin (4%), 3*S.e.* Hadar (4%), and 1*S.e.* Papuana (1%). Twenty-five strains (28%) were multiresistant: 20*S.e. Typhimurium* (80%), 3*S.e.* Enteritidis, 1*S.e.* Papuana, and 1*S.e.* Stanleyville. Among them, twenty-five isolates (28%) including*S.e.* Typhimurium (*n* = 20),*S.e.* Enteritidis (*n* = 3),*S.e.* Papuana (*n* = 1), and*S.e.* Stanleyville (*n* = 1) were multiresistant to antibiotics. The studied patients were constituted by 14 women and 11 men. They were between 1 month and 40 years of age and presented an average age of 11 years. The isolates were isolated from stool (*n* = 11), blood (*n* = 9), cerebrospinal fluid (*n* = 1), and urine (*n* = 1). All strains isolated from blood were represented by*S.e.* Typhimurium. Most of the strains were resistant to amoxicillin, ticarcillin, streptomycin, sulfonamides, and cotrimoxazole and less frequently to cefalotin (4%), ciprofloxacin (2%), gentamycin (3%), and nalidixic acid (4%). All the strains except one ESBL-producing*S.* Typhimurium strain (S1027072) were susceptible to cefoxitin. The ESBL-producing strain was resistant to amikacin, tobramycin, netilmicin, kanamycin, fosfomycin, ceftazidime, cefepime, aztreonam, and nitroxoline; it remained susceptible only to imipenem. Otherwise, two common resistance profiles were observed: 14 (34%) (12*S*. Typhimurium and 2*S*. Enteritidis) were resistant to four drugs (ampicillin, chloramphenicol, streptomycin, and sulfonamides) and 10 (24%) (7*S*. Typhimurium, 1*S*. Enteritidis, one*S.* Hadar, and one*S*. Papuana) were resistant to five drugs (ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline) ([Table 2](#tab2){ref-type="table"}).

All strains carried the catA1 resistance gene, six contained*bla* ~*TEM*~,*dhfrA1*, and *Sul II*, and five contained*sul I.* The genes*bla* ~*OXA*~,*tetA*, and*aadA1* were found only once. The gene*bla* ~*SHV*~ was not found, even in the ESBL-producing strain ([Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

Three serovars of*S.e.* Typhimurium (*n* = 47),*S.e.* Stanleyville (21), and*S.e* Enteritidis (*n* = 18) constituted 96% of the isolated strains.*S.e.* Typhimurium and*S.e.* Enteritidis were the enteric*Salmonella* isolated most frequently \[[@B9], [@B10]\]. The surprisingly high prevalence of*S.* Stanleyville in Bangui may represent a locally circulating strain. The blood isolates were obtained mainly from AIDS patients \[[@B11]--[@B14]\].

*S.e.* Typhimurium was the*Salmonella* serovar that was most resistant to antibiotics. It is confirmed today that its multidrug-resistant strains have emerged in sub-Saharan Africa \[[@B15]\]. In Malawi, epidemics of multidrug-resistant invasive nontyphoidal*Salmonella* (defined as resistant to ampicillin, chloramphenicol, and cotrimoxazole) have been recorded \[[@B15]\]. The continuous increase in its resistance \[[@B16]\] will limit the therapeutic possibilities more and more, as exemplified by the emergence of an ESBL-producing strain (S1027072).

*Salmonella* resistant to four and five drugs are found widely in Africa. Although the prevalence in Bangui is high (58%), up to 82% of*Salmonella* isolates have been reported to be resistant \[[@B16], [@B17], [@B18]\]. Additionally, the prevalence of resistance to chloramphenicol, amoxicillin, and cotrimoxazole was high (72%), as reported in Lomé (Togo) \[[@B17]\], but is even higher in Taiwan (95%) \[[@B19]\]. These three cheap antibiotics used to be the first-line treatment for salmonellosis but can no longer be used. Third-generation cephalosporins and fluoroquinolones remain active against most strains of*Salmonella* in Bangui; in Asia, however, up to 54% of strains are resistant to these two antibiotics \[[@B20], [@B21]\]. Ciprofloxacin (or norfloxacin) is used as first-line treatment, except in children, for whom ceftriaxone is preferred \[[@B22]\]. Systematic use and self-medication with these antibiotics, which can be bought freely, raise concern that there might be a rapid increase in resistance \[[@B16], [@B21]\].

The use of tetracyclines and penicillin as growth promoters in animal husbandry is a factor in the increasing prevalence of resistance \[[@B23]--[@B25]\], but no information on this aspect is available in CAR.

The genes for which we searched only partly explain phenotypic resistance. There are many resistance genes, and one type of in vitro resistance may have several mechanisms. For example, aminoside resistance may be associated with three genes:*aphA* (aminoglycoside phosphotransferase),*aacC* (aminoglycoside acetyltransferases), and*aadA* and*aadB* (two variants of aminoglycoside adenyltransferases) \[[@B24]\], all of which are plasmid-encoded \[[@B25]\]. Antibiotic resistance may also be linked to other mechanisms, such as chromosomal mutations (modification of the ribosome structure, modification of the permeability of the cell wall, and presence of an efflux pump), which cannot be identified by genic amplification. Nevertheless, the presence of five genotypes among the six circulating*S.e.* Typhimurium strains resistant to four and five drugs indicates wide heterogeneity.

The ESBL strain with its seven resistance-associated genes differs from the other six; it is either imported or acquired a plasmid locally. The gene*CTX-M-15* has been described as the commonest in CAR and has been found in*E. coli* and*Klebsiella pneumoniae* strains \[[@B6]\]. As it was not present in the multiresistant*S.e.* Typhimurium strain, its origin remains unknown. It would be difficult to determine which EBSL is present, as no other isolate harboured this enzyme, and 230 ESBLs have been described so far \[[@B26]\]. The isolation of a multiresistant ESBL-producing strain in Bangui is worrying, as its spread would complicate patient care in view of the limited access in the country to the antibiotics to which such strains are susceptible \[[@B4], [@B20], [@B26]\]. A systematic study of isolated*S.e.* Typhimurium strains will be required to determine whether this strain is present in the country. For the moment, this appears unlikely, as no other isolate has been obtained.

The main limitation of our study is that data of the patient characteristics (age, sex, HIV status, malaria status, and malnutrition status) were not collected. Indeed, it would be essential to assess the impact of these characteristics with outcomes.

5. Conclusion {#sec5}
=============

This preliminary study demonstrates a high prevalence of antibiotic-resistant*S.* Typhimurium and diverse associated genes in Bangui. Further studies will elucidate the epidemiology of the antibiotic resistance and make it possible to characterize the genes involved and the plasmids that carry them. In the absence of rational use of antibiotics in the country, continuous dissemination of resistant strains is likely. Systematic antibiograms should be performed for all isolated strains to follow the evolution of resistance and thus ensure effective treatment of infections, which are of particular concern for immunocompromised patients.
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###### 

Primers used for detecting resistance-associated genes by PCR.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene            Enzymatic activity                         Antibiotic targeted                                                         Primers                                    References
  --------------- ------------------------------------------ --------------------------------------------------------------------------- ------------------------------------------ ---------------------------
  *bla* ~*TEM*~   Penicillinase TEM                          Aminopenicillins, carboxypenicillins, and ureidopenicillins                 OT3: 5′ ATGAGTATTCAACATTTCCG 3′ \          \[[@B6], [@B7]\]
                                                                                                                                         OT4: 5′ CCAATGCTTATTCAGTGAGG 3′            

                                                                                                                                                                                    

  *bla* ~*OXA*~   Oxacillinase                               Aminopenicillins, carboxypenicillins, ureidopenicillins, and Penicillin M   OXA F: 5′ ATGAAAACACAATACATATC 3′ \        \[[@B9]\]
                                                                                                                                         OXA R: 5′ AATTTAGTGTGTTTAGAATG 3′          

                                                                                                                                                                                    

  *bla* ~*SHV*~   Beta-lactamase Sulfhydryl Variable (SHV)   All beta-lactams except carbapenems and cephamycins                         OS5: 5′ TTATCTCCCTGTTAGCCACC 3′ \          \[[@B10]\]
                                                                                                                                         OS6: 5′ GATTTGCTGATTTCGCTCGG 3′            

                                                                                                                                                                                    

  *tetA*          Active efflux pump                         Cyclines                                                                    TetA Lower: 5′ GCAGGCAGAGCAAGTAGAGG 3′ \   \[[@B6], [@B11], [@B12]\]
                                                                                                                                         TetA Upper: 5′ GTTTCGGGTTCGGGATGGTC 3′     

                                                                                                                                                                                    

  *catA1*         Chloramphenicol acetyl transferase         Chloramphenicol                                                             CatA1-F: 5′ CGCCTGATGAATGCTCATCCG.3′ \     \[[@B6], [@B13]\]
                                                                                                                                         CatA1-R: 5′ CCTGCCACTCATCGCAGTAC 3′        

                                                                                                                                                                                    

  *aadA1*         Aminoglycoside adenyltransferase           Streptomycin                                                                Aad-F: 5′ TATCAGAGGTAGTTGGCGTCAT 3′ \      \[[@B6], [@B14], [@B16]\]
                                                                                                                                         Aad-R: 5′ GTTCCATAGCGTTAAGGTTTCATT 3′      

                                                                                                                                                                                    

  *dhfrA1*        Dihydrofolate reductase (DHFR)             Trimethoprim                                                                dhfrla-F: 5′ TGAAACTATCACTAATGGTA 3′ \     \[[@B4], [@B17]\]
                                                                                                                                         dhfrla-R: 5′ TTAACCCTTTTGCCAGTATTG 3′      

                                                                                                                                                                                    

  *sul I*         Dihydropteroate synthetase (DHPS)          Sulfonamides                                                                Sul I-F: 5′ CGGCGTGGGCTACCTGAACC 3′ \      \[[@B6], [@B17]\]
                                                                                                                                         Sul I-B: 5′ GCCGATCGCGTGAAGTTCCG 3′        

                                                                                                                                                                                    

  *sul II*        Dihydropteroate synthetase (DHPS)          Sulfonamides                                                                Sul II-F: 5′ GCGCTCAAGGCAGATGGCATT 3′ \    \[[@B6], [@B17]\]
                                                                                                                                         Sul II-B: 5′ GCGTTTGATACCGGCACCCGT 3′      
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Antibiotic resistance of *S. enterica* strains isolated in Bangui.

  Antibiotic                        Resistant strain                                                            
  --------------------------------- ------------------ ---- ---- --- ---- ---- --- ---- --- ---- --- ----- ---- ----
  Ampicillin                        20                 43   1    5   3    17   1   25   2   67   1   100   29   31
  Amoxicillin and clavulanic acid   8                  17   0    0   1    6    0   0    1   33   0   0     11   12
  Ticarcillin                       20                 43   1    5   3    17   1   25   1   33   1   100   28   30
  Cefalotin                         3                  6    1    5   0    0    0   0    0   0    0   0     4    4
  Cefoxitin                         1                  1    0    0   0    0    0   0    0   0    0   0     1    1
  Cefotaxime                        1                  2    0    0   0    0    0   0    0   0    0   0     1    1
  Streptomycin                      20                 43   1    5   3    17   0   0    0   0    1   100   25   27
  Gentamicin                        2                  4    0    0   1    6    0   0    0   0    0   0     3    3
  Nalidixic acid                    3                  6    0    0   1    6    0   0    0   0    0   0     4    4
  Ciprofloxacin                     2                  4    0    0   0    0    0   0    0   0    0   0     2    2
  Chloramphenicol                   20                 43   1    5   3    17   2   50   1   33   1   100   28   30
  Cotrimoxazole                     18                 38   1    5   3    17   2   50   1   33   1   100   26   8
  Sulfonamides                      20                 43   1    5   3    17   1   25   1   33   1   100   27   29
  Tetracycline                      7                  15   1    5   2    11   0   0    0   0    1   100   11   12
  Total                             47                      21       18        4        3        1         94    

^*∗*^Including one expanded-spectrum *β*-lactamase- (ESBL-) producing *S*. Typhimurium strain.

###### 

Antibiotic resistance-associated genes in seven *S.e.* Typhimurium strains.

  Gene                                                                                             *TEM*           *bla* ~*SHV*~         *tetA*               *bla* ~*OXA*~   *aadA1*               *dhfrA1*   *catA1*   *sul I*   *sul II*
  ------------------------------------------------------------------------------------------------ --------------- --------------------- -------------------- --------------- --------------------- ---------- --------- --------- ----------
  Control (+)                                                                                      *S.* Concord    *S. dysenteriae* 1    *S.e.*Typhimurium    *S.* Concord    *S*.*dysenteriae*1                                   
  07-670                                                                                           CAR 10          02-8213               07-670               CAR 10                                                               
                                                                                                                                                                                                                                   
  Strains resistant to ampicillin, chloramphenicol, streptomycin, and sulfonamides                                                                                                                                                 
  S0625010                                                                                         \+              −                     −                    −               −                     \+         \+        \+        \+
  S1107023                                                                                         −               −                     −                    −               −                     −          \+        −         −
  S0621014                                                                                         \+              −                     −                    −               −                     \+         \+        \+        \+
  S1028034                                                                                         \+              −                     −                    −               \+                    \+         \+        \+        \+
                                                                                                                                                                                                                                   
  Strains resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline                                                                                                                                   
  S0626101                                                                                         \+              −                     −                    −               −                     \+         \+        −         \+
  S1003035                                                                                         \+              −                     −                    −               −                     \+         \+        \+        \+
                                                                                                                                                                                                                                   
  ESBL-producing *S.* Typhimurium strain                                                                                                                                                                                           
  S1027072                                                                                         \+              −                     \+                   \+              −                     \+         \+        \+        \+

^+^Gene present; ^−^gene absent.
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